iatroX logo
brainstormaskiatroXuk q-bankus q-bankknowledge centreblog
Knowledge Centre / Macular Degeneration (Age-Related - AMD)

Macular Degeneration (Age-Related - AMD)

Assessment and management of AMD.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
Ophthalmology

Clinical Guidelines

CKS: Macular degeneration - age-related
National
NICE guideline [NG82]
National
NICE guideline [NG82]: Age-related macular degeneration
National
The Royal College of Ophthalmologists' clinical guidelines for age-related macular degeneration
National

Recent iatroX Q&As

  • What are the key clinical features to differentiate between dry and wet age-related macular degeneration (AMD) during assessment?Updated: 8/16/2025
  • Which patients with AMD should be referred to an ophthalmologist for further evaluation and potential treatment?Updated: 8/16/2025
  • What are the recommended monitoring protocols for patients diagnosed with dry AMD in primary care?Updated: 8/16/2025
  • How can I effectively counsel patients on lifestyle modifications to slow the progression of AMD?Updated: 8/16/2025
  • What are the current evidence-based treatment options available for patients with wet AMD in primary care settings?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsightsfaqabout
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play